Cellarity is a groundbreaking startup that is revolutionizing the process of drug creation. The company operates in the pharmaceutical industry, specifically in the area of drug discovery and development. They serve clients in the healthcare sector, including hospitals, clinics, and other medical institutions.

Cellarity's business model is centered around a novel approach to drug discovery. Unlike traditional methods that focus on single molecular targets, Cellarity targets the entire cell, which they believe is a more effective way to treat diseases. This approach is based on a deep understanding of disease biology and leverages advanced technologies like genomics, systems biology, data science, and artificial intelligence (AI).

The company's platform provides insights into cellular dysfunction, revealing new biology that can be used to treat a wide range of diseases. This includes diseases that have been overlooked or are too complex to resolve with traditional methods. With ongoing programs in hematology, immuno-oncology, and metabolism, Cellarity is at the forefront of creating a new generation of medicines.

Cellarity makes money by developing and selling these innovative drugs. Their interdisciplinary team of experts works together to create these new therapies, which are then sold to healthcare providers. The company's unique approach to drug discovery could potentially lead to more effective treatments for a variety of diseases, making it a promising player in the pharmaceutical industry.

Keywords: Drug Creation, Disease Biology, Cellular Dysfunction, Drug Discovery, Genomic Technologies, Systems Biology, Data Science, Artificial Intelligence, Hematology, Immuno-Oncology.